Product Overview

Pazib (Pazopanib) is an oral medication used primarily in the treatment of advanced renal cell carcinoma (kidney cancer) and soft tissue sarcoma. It functions as a tyrosine kinase inhibitor, targeting specific pathways that contribute to cancer growth and spread.

Indications

Pazib is indicated for the treatment of:

• Advanced renal cell carcinoma in adults.
• Soft tissue sarcoma in adults after prior chemotherapy.

Mechanism of Action

Pazopanib works by inhibiting multiple tyrosine kinases involved in tumor growth, angiogenesis, and metastasis. This helps to slow down or stop the growth of cancer cells.

Dosage Information

The recommended dosage of Pazib should be determined by a healthcare professional based on individual patient factors. It is typically taken once daily, with or without food.

Potential Side Effects

Common side effects of Pazib may include:

• Nausea and vomiting
• Diarrhea
• Fatigue
• Loss of appetite
• Hypertension

Serious side effects can occur and should be reported to a healthcare provider immediately.

Contraindications

Pazib should not be used in patients with:

• Severe liver impairment
• Known hypersensitivity to Pazopanib or any of its components

Drug Interactions

Inform your healthcare provider about all medications you are taking, as Pazib may interact with certain drugs, potentially affecting its efficacy and safety.

Storage Instructions

Store Pazib at room temperature, away from moisture and heat. Keep out of reach of children.

Consultation and Monitoring

Regular monitoring and consultations with a healthcare provider are essential to ensure the efficacy of treatment and to manage any potential side effects.